Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29297314 | 0.82 | NNMT (0.36) | NNMT | |
| SCHEMBL7914306 | 0.77 | NNMT (0.58) | NNMTTSHR | |
| SCHEMBL21729487 | 0.77 | NNMT (0.58) | NNMTTSHR | |
| SCHEMBL20075991 | 0.76 | NNMT (0.56) | NNMTTSHR | |
| SCHEMBL26822879 | 0.72 | NNMT (0.31) | NNMT | |
| SCHEMBL25427657 | 0.70 | NNMT (1.00) | NNMT | |
| SCHEMBL24722680 | 0.69 | NNMT (0.32) | NNMT | |
| SCHEMBL84156 | 0.69 | NNMT (0.49) | NNMTTSHR | |
| SCHEMBL15910099 | 0.67 | MB (0.32) | — | |
| SCHEMBL20088870 | 0.67 | CREBBP (0.35) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180118740-A1 | AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS | JANSSEN PHARMACEUTICA NV (BE) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118740-A1 | AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS | GRIN1, GRIN2B, GRIN3A | NNMT 196/4885TSHR 628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.